Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Services industry

Amyotrophic Lateral Sclerosis Als Market 2020 By Manufacturers, Regions, Types, Applications And Forecast To 2026

  • Code : SMI27298
  • Pages : 112
  • Date : Aug, 2020
  • Category : Services
  • Publisher : SMI
  • Format : SMI PPT FormatSMI PDF Format

  • Purchase Options

 

Summary

The global Amyotrophic Lateral Sclerosis Als Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Amyotrophic Lateral Sclerosis Als Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Amyotrophic Lateral Sclerosis Als Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Mitsubishi Tanabe Pharma
  • Sanofi
  • Mylan Pharma
  • Apotex
  • Glemark Generics
  • Covis Pharma
  • Sun Pharma
  • Lunan Pharma

By the Product Type, the market is primarily segmented into:

  • Riluzole
  • Edaravone (Radicava)
  • Other

By Applications, the market is segmented into:

  • Hospital
  • Drugs Store
  • Other

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Amyotrophic Lateral Sclerosis Als Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Amyotrophic Lateral Sclerosis Als Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Amyotrophic Lateral Sclerosis Als Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Amyotrophic Lateral Sclerosis Als Market

The Amyotrophic Lateral Sclerosis Als Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Amyotrophic Lateral Sclerosis Als Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

1 Study Coverage
1.1 Amyotrophic Lateral Sclerosis (ALS) Product Introduction
1.2 Market Segments
1.3 Key Amyotrophic Lateral Sclerosis (ALS) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Type
1.4.2 Riluzole
1.4.3 Edaravone (Radicava)
1.4.4 Other
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drugs Store
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Amyotrophic Lateral Sclerosis (ALS) Industry Impact
1.6.1 How the Covid-19 is Affecting the Amyotrophic Lateral Sclerosis (ALS) Industry
1.6.1.1 Amyotrophic Lateral Sclerosis (ALS) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Amyotrophic Lateral Sclerosis (ALS) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Amyotrophic Lateral Sclerosis (ALS) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Estimates and Forecasts
2.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Revenue 2015-2026
2.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales 2015-2026
2.2 Amyotrophic Lateral Sclerosis (ALS) Market Size by Region: 2020 Versus 2026
2.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Amyotrophic Lateral Sclerosis (ALS) Competitor Landscape by Players
3.1 Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturers
3.1.1 Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturers (2015-2020)
3.1.2 Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Manufacturers (2015-2020)
3.2 Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers
3.2.1 Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers (2015-2020)
3.2.2 Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (ALS) Revenue in 2019
3.2.5 Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Amyotrophic Lateral Sclerosis (ALS) Price by Manufacturers
3.4 Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base Distribution, Product Types
3.4.1 Amyotrophic Lateral Sclerosis (ALS) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type
3.4.3 Date of International Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Type (2015-2020)
4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020)
4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2015-2020)
4.1.3 Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Type (2021-2026)
4.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Type (2021-2026)
4.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Type (2021-2026)
4.2.3 Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Application (2015-2020)
5.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020)
5.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2015-2020)
5.1.3 Amyotrophic Lateral Sclerosis (ALS) Price by Application (2015-2020)
5.2 Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Application (2021-2026)
5.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Application (2021-2026)
5.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Application (2021-2026)
5.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Amyotrophic Lateral Sclerosis (ALS) by Country
6.1.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country
6.1.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
6.3 North America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application

7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (ALS) by Country
7.1.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country
7.1.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) by Region
8.1.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region
8.1.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
8.3 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis (ALS) by Country
9.1.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country
9.1.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
9.3 Central & South America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) by Country
10.1.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country
10.1.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
10.3 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application

11 Company Profiles
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Corporation Information
11.1.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.1.5 Mitsubishi Tanabe Pharma Recent Development
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description, Business Overview and Total Revenue
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.2.5 Sanofi Recent Development
11.3 Mylan Pharma
11.3.1 Mylan Pharma Corporation Information
11.3.2 Mylan Pharma Description, Business Overview and Total Revenue
11.3.3 Mylan Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.3.5 Mylan Pharma Recent Development
11.4 Apotex
11.4.1 Apotex Corporation Information
11.4.2 Apotex Description, Business Overview and Total Revenue
11.4.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.4.5 Apotex Recent Development
11.5 Glemark Generics
11.5.1 Glemark Generics Corporation Information
11.5.2 Glemark Generics Description, Business Overview and Total Revenue
11.5.3 Glemark Generics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.5.5 Glemark Generics Recent Development
11.6 Covis Pharma
11.6.1 Covis Pharma Corporation Information
11.6.2 Covis Pharma Description, Business Overview and Total Revenue
11.6.3 Covis Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.6.5 Covis Pharma Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Corporation Information
11.7.2 Sun Pharma Description, Business Overview and Total Revenue
11.7.3 Sun Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.7.5 Sun Pharma Recent Development
11.8 Lunan Pharma
11.8.1 Lunan Pharma Corporation Information
11.8.2 Lunan Pharma Description, Business Overview and Total Revenue
11.8.3 Lunan Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.8.5 Lunan Pharma Recent Development
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Corporation Information
11.1.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
11.1.5 Mitsubishi Tanabe Pharma Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Projections by Region
12.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Regions 2021-2026
12.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Regions 2021-2026
12.2 North America Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
12.2.1 North America: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
12.2.2 North America: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
12.2.3 North America: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)
12.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
12.3.1 Europe: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
12.3.2 Europe: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
12.3.3 Europe: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Region (2021-2026)
12.5 Latin America Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
12.5.1 Latin America: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
12.5.2 Latin America: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
12.5.3 Latin America: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key Amyotrophic Lateral Sclerosis (ALS) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amyotrophic Lateral Sclerosis (ALS) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details

List of Table
List of Tables
Table 1. Amyotrophic Lateral Sclerosis (ALS) Market Segments
Table 2. Ranking of Global Top Amyotrophic Lateral Sclerosis (ALS) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Riluzole
Table 5. Major Manufacturers of Edaravone (Radicava)
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Amyotrophic Lateral Sclerosis (ALS) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Amyotrophic Lateral Sclerosis (ALS) Players to Combat Covid-19 Impact
Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Regions 2015-2020 (K MT)
Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Regions (2015-2020)
Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Manufacturers (2015-2020)
Table 19. Global Amyotrophic Lateral Sclerosis (ALS) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Amyotrophic Lateral Sclerosis (ALS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) as of 2019)
Table 21. Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Price (2015-2020) (USD/MT)
Table 24. Amyotrophic Lateral Sclerosis (ALS) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type
Table 26. Date of International Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020) (K MT)
Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Type (2015-2020)
Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Type (2015-2020)
Table 32. Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020) (K MT)
Table 34. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Application (2015-2020)
Table 35. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2015-2020) (K MT)
Table 36. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2015-2020)
Table 37. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2015-2020)
Table 39. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020) (K MT)
Table 40. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2015-2020)
Table 41. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020) (K MT)
Table 42. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2015-2020)
Table 43. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2015-2020) (K MT)
Table 44. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2015-2020)
Table 45. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2015-2020)
Table 47. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020) (K MT)
Table 48. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2015-2020)
Table 49. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020) (K MT)
Table 50. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2015-2020)
Table 59. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2015-2020) (K MT)
Table 60. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2015-2020)
Table 63. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020) (K MT)
Table 64. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2015-2020)
Table 65. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020) (K MT)
Table 66. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2015-2020)
Table 75. Mitsubishi Tanabe Pharma Corporation Information
Table 76. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 77. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Mitsubishi Tanabe Pharma Product
Table 79. Mitsubishi Tanabe Pharma Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Major Businesses
Table 82. Sanofi Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi Product
Table 84. Sanofi Recent Development
Table 85. Mylan Pharma Corporation Information
Table 86. Mylan Pharma Description and Major Businesses
Table 87. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Mylan Pharma Product
Table 89. Mylan Pharma Recent Development
Table 90. Apotex Corporation Information
Table 91. Apotex Description and Major Businesses
Table 92. Apotex Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Apotex Product
Table 94. Apotex Recent Development
Table 95. Glemark Generics Corporation Information
Table 96. Glemark Generics Description and Major Businesses
Table 97. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Glemark Generics Product
Table 99. Glemark Generics Recent Development
Table 100. Covis Pharma Corporation Information
Table 101. Covis Pharma Description and Major Businesses
Table 102. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Covis Pharma Product
Table 104. Covis Pharma Recent Development
Table 105. Sun Pharma Corporation Information
Table 106. Sun Pharma Description and Major Businesses
Table 107. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sun Pharma Product
Table 109. Sun Pharma Recent Development
Table 110. Lunan Pharma Corporation Information
Table 111. Lunan Pharma Description and Major Businesses
Table 112. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Lunan Pharma Product
Table 114. Lunan Pharma Recent Development
Table 115. Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Regions (2021-2026) (K MT)
Table 116. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2021-2026) (K MT)
Table 120. North America: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2021-2026) (K MT)
Table 122. Europe: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Region (2021-2026) (K MT)
Table 124. Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2021-2026) (K MT)
Table 126. Latin America: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2021-2026) (K MT)
Table 128. Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Amyotrophic Lateral Sclerosis (ALS) Players
Table 133. Amyotrophic Lateral Sclerosis (ALS) Customers List
Table 134. Amyotrophic Lateral Sclerosis (ALS) Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis (ALS) Product Picture
Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type in 2020 & 2026
Figure 3. Riluzole Product Picture
Figure 4. Edaravone (Radicava) Product Picture
Figure 5. Other Product Picture
Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Drugs Store
Figure 9. Other
Figure 10. Amyotrophic Lateral Sclerosis (ALS) Report Years Considered
Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Market Size 2015-2026 (US$ Million)
Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Sales 2015-2026 (K MT)
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2015-2020)
Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region in 2019
Figure 16. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2015-2020)
Figure 17. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region in 2019
Figure 18. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Revenue in 2019
Figure 20. Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2015-2020)
Figure 22. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type in 2019
Figure 23. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2015-2020)
Figure 24. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type in 2019
Figure 25. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Price Range (2015-2020)
Figure 26. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2015-2020)
Figure 27. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application in 2019
Figure 28. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2015-2020)
Figure 29. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application in 2019
Figure 30. North America Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2019
Figure 33. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2019
Figure 34. U.S. Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2019
Figure 39. North America Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2019
Figure 40. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2019
Figure 43. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2019
Figure 44. Germany Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2019
Figure 55. Europe Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2019
Figure 56. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region in 2019
Figure 59. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region in 2019
Figure 60. China Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2019
Figure 83. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2019
Figure 84. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2019
Figure 87. Latin America Amyotrophi
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us